Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/2012
12/13/2012US20120315634 Distinguishing pca3 messenger rna species in benign and malignant prostate tissues
12/13/2012US20120315631 Tumor suppressor designated ts10q23.3
12/13/2012US20120315335 Self-assembling nanoparticle drug delivery system
12/13/2012US20120315334 Pharmaceutical or neutraceutical formulation
12/13/2012US20120315330 Pharmaceutical composition for the treatment of acute disorders
12/13/2012US20120315325 Peptide pharmaceutical for oral delivery
12/13/2012US20120315324 Exosomal compositions and methods for the treatment of disease
12/13/2012US20120315305 Dry Powder Fibrin Sealant
12/13/2012US20120315304 Sensitization of immune system against haptenized melanoma antigens
12/13/2012US20120315290 Inhibitors of ll-37 mediated immune reactivity to self nucleic acids
12/13/2012US20120315288 LOW DENSITY LIPOPROTEIN RECEPTOR-MEDIATED siRNA DELIVERY
12/13/2012US20120315286 Compositions and methods related to tim 3, a th1-specific cell surface molecule
12/13/2012US20120315284 Composition for enhancing trail sensitivity comprising inhibitors for expression or activity of tip41 as a target gene of trail sensitizer
12/13/2012US20120315283 Methods of promoting tissue growth and tissue regeneration
12/13/2012US20120315279 Compositions and method of modulating growth factor function
12/13/2012US20120315274 Methods of Treating Glucose Metabolism Disorders
12/13/2012US20120315265 Hydrogel-forming polymer, and preparation process and uses thereof
12/13/2012US20120315264 Zwitterionic immunomodulators for the teatment of asthma and allergy
12/13/2012US20120315263 Pharmaceutical compositions containing protease and methods for the treatment of lysosomal storage diseases
12/13/2012US20120315262 Stabilized open form transglutaminase as a diagnostic indictor for autoimmune diseases
12/13/2012US20120315261 Antibacterial auxiliary agent comprising kombu extract as active ingredient, antibacterial composition, and food or beverage
12/13/2012US20120315260 Compositions and Methods to Prevent and Treat Biofilms
12/13/2012US20120315259 Method and composition for skin care comprising cord blood serum or plasma or components thereof
12/13/2012US20120315256 Use of transforming growth factor - beta 1 (tgf-b1) inhibitor peptides for the treatment of corneal fibrosis and/or haze
12/13/2012US20120315247 Compounds comprising a spiro-ring and methods of use
12/13/2012US20120315246 Compositions and methods for modulating inflammatory and/or immune responses
12/13/2012US20120315245 Immunomodulator polypeptides derived from il-2 and their use thereof in the therapeutic of cancer and chronic infections
12/13/2012US20120315244 Methods for Modulation of Autophagy Through the Modulation of Autophagy-Inhibiting Gene Products
12/13/2012US20120315243 Methods and kits for reducing the likelihood of implantation failure and pregnancy-related disorders in recipients of artificial insemination
12/13/2012US20120315234 Composition for hair and body application
12/13/2012US20120315221 Human sample matching system
12/13/2012US20120315220 Compounds for Targeting Endothelial Cells, Compositions Containing the Same and Methods for Their Use
12/13/2012US20120315219 Drug Delivery Coating For Use With A Stent
12/13/2012CA2838845A1 Treatment of coagulation disease by administration of recombinant vwf
12/13/2012CA2838833A1 Pro-coagulant compounds and methods of use thereof
12/13/2012CA2838824A1 Modulation of pancreatic beta cell proliferation
12/13/2012CA2838818A1 Methods of treatment for retinal diseases
12/13/2012CA2838573A1 Treatment of cancers and metastases with suspensions of cilengitide in carrier
12/13/2012CA2838503A1 Novel oxyntomodulin derivatives and pharmaceutical composition for treating obesity comprising the same
12/13/2012CA2838490A1 Targets and agents for the treatment of impaired bone fracture healing
12/13/2012CA2838474A1 Shk-based pharmaceutical compositions and methods of manufacturing and using the same
12/13/2012CA2838262A1 Methods of phosvitin extraction and phosphopeptide preparation from egg yolk
12/13/2012CA2838186A1 Scaffold-kinase interaction blockades and uses thereof in treating cancer
12/13/2012CA2838155A1 Methods for repairing tissue damage using protease-resistant mutants of stromal cell derived factor-1
12/13/2012CA2838069A1 Lipid nanoparticle compositions and methods for mrna delivery
12/13/2012CA2838037A1 Beta-hairpin peptidomimetics as cxc4 antagonists
12/13/2012CA2838013A1 Pseudomonas exotoxin a with less immunogenic t cell and/or b cell epitopes
12/13/2012CA2837995A1 Method of producing factor viii proteins by recombinant methods
12/13/2012CA2837979A1 Macromolecules
12/13/2012CA2837767A1 Cetp fragments
12/13/2012CA2837474A1 Pharmaceutical compositions containing proteases and methods for the treatment of lysosomal storage diseases
12/13/2012CA2837445A1 Therapeutic agents for regulating serum phosphorus
12/13/2012CA2836925A1 Retinoid-liposomes for enhancing modulation of hsp47 expression
12/12/2012EP2532742A1 Production and purification of recombinant arylsulfatase A
12/12/2012EP2532675A1 Long-acting polypeptides and methods of producing and administering same
12/12/2012EP2532674A1 Long-acting polypeptides and methods of producing and administering same
12/12/2012EP2532359A1 CETP fragments
12/12/2012EP2532358A1 Therapeutic Agent for Infections
12/12/2012EP2532357A2 Cell-permeable peptide inhibitors of the JNK signal transduction pathway
12/12/2012EP2532356A1 Implantable power sources and sensors
12/12/2012EP2531616A1 Diagnostic and prognostic assay for breast cancer
12/12/2012EP2531599A2 Compositions and methods for re-programming cells without genetic modification for treatment of neurological disorders
12/12/2012EP2531597A2 Engineered enzymes with methionine-gamma-lyase enzymes and pharmacological preparations therof
12/12/2012EP2531524A1 Fusion proteins comprising antigenic apob-100 protein fragments and a protein carrier, related compositions, methods and systems for treatment and/or prevention of atherosclerosis
12/12/2012EP2531522A1 Antimicrobial peptides of the cecropin family and therapeutic uses thereof
12/12/2012EP2531521A1 Use of proteases for gluten intolerance
12/12/2012EP2531519A1 Lantibiotic salts
12/12/2012EP2531518A1 Oligopeptidic compounds and uses thereof
12/12/2012EP2531517A2 Caspase-14 activator peptides and compositions comprising said peptides
12/12/2012EP2531220A2 Active scaffolds for on-demand drug and cell delivery
12/12/2012EP2531211A1 Method for sensitizing cells to cancer therapy
12/12/2012EP2531209A2 Compositions of prokaryotic phenylalanine ammonia-lyase variants and methods of using compositions thereof
12/12/2012EP2531208A1 Treatment of fibrosis-related disorders using fibronectin binding proteins and polypeptides
12/12/2012EP2531207A2 Methods and compositions for cancer immunotherapy using flagellin-tumor associated antigen fusion protein expressing tumor cells
12/12/2012EP2531206A1 Chlorotoxin polypeptides and conjugates and uses thereof
12/12/2012EP2531205A1 Actagardine derivatives, and pharmaceutical use thereof
12/12/2012EP2531204A1 Template - fixed peptidomimetics with cxcr7 modulating activity
12/12/2012EP2531195A1 Use of theobromine for lowering central blood pressure
12/12/2012EP2531027A1 Antiviral therapy
12/12/2012DE202011109558U1 Zusammensetzung für die topische Anwendung bei entzündlichen Erkrankungen der Haut und/oder Schleimhaut Composition for topical use in inflammatory diseases of the skin and / or mucosa
12/12/2012CN1890567B Angiogenesis inhibiting molecules and their use in the treatment and diagnosis of cancer
12/12/2012CN1810832B Dimeric thrombopoietin peptide mimetics binding to MP1 receptor and having thrombopoietic activity
12/12/2012CN1678734B Differentiation modulating agents and uses thereof
12/12/2012CN1484650B Urocortin proteins and uses thereof
12/12/2012CN102822198A CTLA4 proteins and their uses
12/12/2012CN102822197A BMP-7 variants with reduced immunogenicity
12/12/2012CN102822194A Treatments for gastrointestinal disorders
12/12/2012CN102822193A Modified MELK peptides and vaccines containing the same
12/12/2012CN102822192A Pyruvamide compounds as inhibitors of dust mite group 1 peptidase allergen and their use
12/12/2012CN102821784A Aminoacyl tRNA synthetases for modulating inflammation
12/12/2012CN102821783A Usion proteins and methods for treating HIV infection and AIDS related symptoms
12/12/2012CN102821782A Liquid formulation of follicle stimulating hormone
12/12/2012CN102821781A Methods for treating parkinson's disease and other disorders of dopaminergic neurons of the brain
12/12/2012CN102821780A Diagnosis of restenosis in patients undergoing percutaneous coronary intervention
12/12/2012CN102821779A Novel peptides and methods for their preparation and use
12/12/2012CN102821778A Composition for increasing trail sensitivity, containing an inhibitor for inhibiting the expression or activity of TIP41 which is a trail sensitizer target gene
12/12/2012CN102821777A Use of a neurofilament peptide for the treatment of glioma
12/12/2012CN102821776A Desmopressin for reducing nocturnal voids
12/12/2012CN102821775A Pharmaceutical compositions of growth hormone secretagogue receptor ligands
12/12/2012CN102821755A Fast dissolving pharmaceutical composition
1 ... 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 ... 3163